453
Views
16
CrossRef citations to date
0
Altmetric
Rapid Communication

Rates of killing of methicillin-resistant Staphylococcus aureus by ceftaroline, daptomycin, and telavancin compared to that of vancomycin

, &
Pages 620-622 | Received 31 Dec 2011, Accepted 20 Feb 2012, Published online: 05 Jun 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Bernardetta Segatore, Domenico Setacci, Francesca Marcoccia & Gianfranco Amicosante. (2017) Ceftaroline in vitro activity against methicillin-resistant Staphylococcus aureus and coagulase-negative Staphylococci: a short report from Italy. Journal of Chemotherapy 29:2, pages 118-121.
Read now
Yoav Keynan & Ethan Rubinstein. (2012) Telavancin in the treatment of invasive Gram-positive infections. Clinical Audit 4, pages 25-29.
Read now
Praveena Marconescu, Edward A. Graviss & Daniel M. Musher. (2012) CORRIGENDUM. Scandinavian Journal of Infectious Diseases 44:11, pages 884-884.
Read now

Articles from other publishers (12)

Nuri Ari Efiana, Aida Dizdarević, Christian W. Huck & Andreas Bernkop-Schnürch. (2019) Improved Intestinal Mucus Permeation of Vancomycin via Incorporation Into Nanocarrier Containing Papain-Palmitate. Journal of Pharmaceutical Sciences 108:10, pages 3329-3339.
Crossref
Debora Sweeney, Dean L. Shinabarger, Jennifer I. Smart, Jon Bruss & Chris M. Pillar. (2017) Evaluation of the bactericidal activity of Telavancin against Staphylococcus aureus using revised testing guidelines. Diagnostic Microbiology and Infectious Disease 89:1, pages 83-85.
Crossref
Kenneth VI Rolston, Weiqun Wang, Lior Nesher, Jordan R. Smith, Michael J. Rybak & Randall A. Prince. (2017) Time-kill determination of the bactericidal activity of telavancin and vancomycin against clinical methicillin-resistant Staphylococcus aureus isolates from cancer patients. Diagnostic Microbiology and Infectious Disease 87:4, pages 338-342.
Crossref
Abrar K. Thabit, David P. Nicolau & Joseph L. Kuti. (2016) In Vitro Pharmacodynamics of Human Simulated Exposures of Telavancin against Methicillin-Susceptible and -Resistant Staphylococcus aureus with and without Prior Vancomycin Exposure . Antimicrobial Agents and Chemotherapy 60:1, pages 222-228.
Crossref
Eric Wenzler, Siyun Liao & Keith A. Rodvold. 2016. Antibiotic Pharmacodynamics. Antibiotic Pharmacodynamics 285 315 .
Christoph Lübbert, Arne C. Rodloff & Kamal Hamed. (2015) Real-World Treatment of Enterococcal Infections with Daptomycin: Insights from a Large European Registry (EU-CORE). Infectious Diseases and Therapy 4:3, pages 259-271.
Crossref
K.V.K. Mohan, S. Sainath Rao, Y. Gao & C.D. Atreya. (2014) Enhanced antimicrobial activity of peptide-cocktails against common bacterial contaminants of ex vivo stored platelets. Clinical Microbiology and Infection 20:1, pages O39-O46.
Crossref
Mina Pastagia, Raymond Schuch, Vincent A. Fischetti & David B. Huang. (2013) Lysins: the arrival of pathogen-directed anti-infectives. Journal of Medical Microbiology 62:10, pages 1506-1516.
Crossref
R. A. Seaton, K. N. Malizos, P. Viale, P. Gargalianos-Kakolyris, T. Santantonio, E. Petrelli, R. Pathan, M. Heep & R. L. Chaves. (2013) Daptomycin use in patients with osteomyelitis: a preliminary report from the EU-CORESM database. Journal of Antimicrobial Chemotherapy 68:7, pages 1642-1649.
Crossref
Kyle P. Murray, Jing J. Zhao, Susan L. Davis, Ravina Kullar, Keith S. Kaye, Paul Lephart & Michael J. Rybak. (2013) Early Use of Daptomycin Versus Vancomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia With Vancomycin Minimum Inhibitory Concentration >1 mg/L: A Matched Cohort Study. Clinical Infectious Diseases 56:11, pages 1562-1569.
Crossref
Aurélie Mélard, Laetitia G. Garcia, Debaditya Das, Raoul Rozenberg, Paul M. Tulkens, Françoise Van Bambeke & Sandrine Lemaire. (2013) Activity of ceftaroline against extracellular (broth) and intracellular (THP-1 monocytes) forms of methicillin-resistant Staphylococcus aureus: comparison with vancomycin, linezolid and daptomycin. Journal of Antimicrobial Chemotherapy 68:3, pages 648-658.
Crossref
Matteo Bassetti, Maria Merelli, Chiara Temperoni & Augusta Astilean. (2013) New antibiotics for bad bugs: where are we?. Annals of Clinical Microbiology and Antimicrobials 12:1, pages 22.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.